Human Antihemophilic Factor class drugs
1 result
Recombinate (antihemophilic factor recombinant)
(antihemophilic factor recombinant)Takeda Pharmaceuticals America, Inc.
Usage: RECOMBINATE (Antihemophilic Factor, Recombinant) is indicated for the prevention and control of bleeding episodes in hemophilia A and for perioperative management in these patients. It may also be used in patients with acquired Factor VIII inhibitors below 10 Bethesda Units/mL. Not indicated for von Willebrand's disease.